Page 96 - Abt News Today

Alpha Cubed Investments LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,104 shares of the healthcare product maker’s stock after selling 398 shares during the period. Alpha Cubed Investments […]

Leavell Investment Management Inc. cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,377 shares of the healthcare product maker’s stock after selling 1,210 shares during the quarter. Leavell Investment Management […]

Eastern Bank lowered its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% in the second quarter, Holdings Channel.com reports. The firm owned 191,602 shares of the healthcare product maker’s stock after selling 8,376 shares during the period. Eastern Bank’s holdings in Abbott Laboratories were worth $20,888,000 at the end of the most recent […]

Eastern Bank lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 191,602 shares of the healthcare product maker’s stock after selling 8,376 shares during the period. Eastern Bank’s holdings in Abbott Laboratories were […]

Independent Investors Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 18.2% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 36,050 shares of the healthcare product maker’s stock after selling 8,018 shares during the quarter. Abbott Laboratories comprises about […]

Essex Savings Bank increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,848 shares of the healthcare product maker’s stock after acquiring an additional 213 shares during the period. Essex […]

Fulton Breakefield Broenniman LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,978 shares of the healthcare product maker’s stock after selling 1,547 shares during the period. Fulton Breakefield […]

Culbertson A N & Co. Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,726 shares of the healthcare product maker’s stock after selling 355 shares […]

Grimes & Company Inc. reduced its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,325 shares of the healthcare product maker’s stock after selling 135 shares during the period. […]

Tandem Investment Advisors Inc. raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 914,183 shares of the healthcare product maker’s stock after buying an additional 52,492 shares during the period. Abbott Laboratories makes […]